Skip to main content
. 2022 Feb 5;20:69. doi: 10.1186/s12951-022-01278-z

Fig. 3.

Fig. 3

a The preparation and action mechanism of NH2-MIL-88b (Fe) in cancer cells [35]. b The apoptosis of cancer cells (A375 and HeLa) and normal cells (HUVEC) induced by synergistic therapy. Reproduced with permission. [35]

Copyright 2020, WILEY–VCH. c The synthesis process of MD@Lip and the action mechanism of MD@Lip in cancer cells [38]. d The tumor volume and body weights of mice during 14-day treatment. Reproduced with permission. [38] Copyright 2019, WILEY–VCH. e The preparation process of PYSNPs and PHNPs and the mechanism of pH-activated PYSNPs releasing Fe [41]. f The relative tumor volume and survival curves of mice after different treatments. Reproduced with permission. [41] Copyright 2019, WILEY–VCH